ERYTECH Pharma Voting Results by Resolution from Annual General Meeting Held on June 21, 2019 Post author:admERY Post published:July 4, 2019 Post category:Newsroom You Might Also Like ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar April 28, 2022 ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019 ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 6, 2021
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar April 28, 2022
ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC June 26, 2019
